Implications of CJD data need to be clear before release

doi:10.1136/bmj.321.7262.701

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Andrew Thornett, clinical research fellow (eanador@soton.ac.uk)

Department of Psychiatry, University of Southampton, Southampton SO14 0YG

EDITOR—Reports surrounding the analysis of tonsillar and appendix tissue for evidence of variant Creutzfeldt-Jakob disease (vCJD)1 have highlighted the difficulty faced by scientists in presenting complex and emotive medical information to the public. Great care is needed, especially when the implications of results are uncertain.

The discovery of prion protein in an appendix removed from a patient in Torbay in 1995 before the onset of clinical …